Sensitive ASX Announcement

FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE

Published: 02/11/26, 10:37am (AEST)•2 pages
Neuren Pharmaceuticals
NEU:ASX•Healthcare

Recent NEU Announcements

Price Sensitive only